This report provides an analysis of the product pipeline of Eqalix, Inc., a biotechnology company developing novel nano-materials for tissue repair and regeneration. The report details Eqalix's six pipeline products which are in various stages of development, including plant-protein based nano-fiber scaffolds and small-diameter hybrid blood vessels. Each product's description, development status and indication are described. The report also provides an overview of Eqalix's business and locations, and is intended to help readers understand Eqalix's portfolio and commercialization strategy.
http://MedicalDeviceEvents.com At the 10x Medical Device Conference in 2014, presenters Carrie Kuehn, Jorge Ochoa, and Robert Packard explained why, according to data from FDA, more than 58% of 510(k) submissions were refused under FDA’s Refuse to Accept (RTA) policy during its first year of implementation.
This presentation examined some of the reasons why industry got such a bad “grade.” We discussed the RTA requirements and some of the challenges from industry’s perspective on meeting the requirements of the RTA checklist and ended with recommendations on how industry can improve its odds of getting past the RTA hurdle on the first try.
Impartial feasibility studies focused on Caffeine manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/caffeine-production-processes
Ethocle Reports has published its latest Market Research Report on Cardiac Valve Repairs. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Satisfying us and eu human factors requirements for inhaler devicesCambridge Consultants
HFE is an essential and integral part of the inhaler device development process. The process requirements are primarily based on the core principles of safety and effectiveness. The HFE processes for the FDA and EU submissions are largely harmonized, but there are some minor differences. It is important that manufacturers of inhaler devices understand the process clearly so that they can comply with the requirements. Following the HFE process does not only fulfil the regulatory requirements but also helps you to develop better products. This presentation provides the holistic view of the HFE process in a simple schematic way, however every project is different and the process should be tailored accordingly.
This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/diarrhea-pipeline-review-h1-2015-report.html
Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies To Ensure...Best Practices
In the face of cost and regulatory pressures, clinical programs at medical device organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities. Emerging markets are also fast-growing regions that present future growth opportunities for organizations that have seen sales growth slow in mature markets. However, there are still questions around the cost, acceptability, quality and pitfalls of conducting clinical trials in emerging regions.
Best Practices®, LLC conducted primary research to inform clinical affairs leaders at medical device companies on emerging approaches to staffing, outsourcing and managing clinical trials outside of the European and U.S. regions.
Critical outsourcing questions addressed in this survey include:
-What are the regions where medical device companies are conducting clinical trials and the percent of patients recruited annually from these regions?
-Which clinical trial activities are best suited for outsourcing?
-What is the appropriate staffing mix (in-house and outsourced) for clinical trials?
-What are the most important competencies for clinical research associates, managers, and directors?
This report will inform Clinical Affairs leaders on these questions and others regarding staffing, outsourcing and managing clinical trials outside of the U.S.
Ethocle Reports has published its latest Market Research Report on Cardiac Valve Repairs - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Ethocle Reports has published its latest Market Research Report on Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Ethocle Reports has published its latest Market Research Report on Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Ethocle Reports has published its latest Market Research Report on Ventricular Assist Devices. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Techno-economic analyses of specific Laurolactam production processes, presenting capital investment breakdown, raw materials consumed and operating costs. Know more at www.intratec.us/products/laurolactam-production-processes
Global Markets Direct's, 'Carcinomas - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Carcinomas, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23246/Carcinomas-%E2%80%93-Pipeline-Review,-H1-2013/
Economics of Aminoundecanoic Acid Production ProcessesIntratec Solutions
Impartial feasibility studies focused on Aminoundecanoic Acid manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/aminoundecanoic-acid-production-processes
Top 10 'MUST DO' Hotel Strategies to Boost Direct BookingsTA Fastrack
Listen to Adrian Caruso, Australia's leading hotel business improvement and marketing expert share with you the top 10 'MUST DO' strategies to drive more direct bookings and instantly boost revenue.
Introduction to Machine Learning for newcomers. It will show you some basic concepts like what is supervised learning, unsupervised learning, classification, regression, under/overfitting, clustering, anomaly detection, and how to have some measures. It will illustrates examples through scikit-learn and tensorflow code
http://MedicalDeviceEvents.com At the 10x Medical Device Conference in 2014, presenters Carrie Kuehn, Jorge Ochoa, and Robert Packard explained why, according to data from FDA, more than 58% of 510(k) submissions were refused under FDA’s Refuse to Accept (RTA) policy during its first year of implementation.
This presentation examined some of the reasons why industry got such a bad “grade.” We discussed the RTA requirements and some of the challenges from industry’s perspective on meeting the requirements of the RTA checklist and ended with recommendations on how industry can improve its odds of getting past the RTA hurdle on the first try.
Impartial feasibility studies focused on Caffeine manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/caffeine-production-processes
Ethocle Reports has published its latest Market Research Report on Cardiac Valve Repairs. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Satisfying us and eu human factors requirements for inhaler devicesCambridge Consultants
HFE is an essential and integral part of the inhaler device development process. The process requirements are primarily based on the core principles of safety and effectiveness. The HFE processes for the FDA and EU submissions are largely harmonized, but there are some minor differences. It is important that manufacturers of inhaler devices understand the process clearly so that they can comply with the requirements. Following the HFE process does not only fulfil the regulatory requirements but also helps you to develop better products. This presentation provides the holistic view of the HFE process in a simple schematic way, however every project is different and the process should be tailored accordingly.
This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/diarrhea-pipeline-review-h1-2015-report.html
Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies To Ensure...Best Practices
In the face of cost and regulatory pressures, clinical programs at medical device organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities. Emerging markets are also fast-growing regions that present future growth opportunities for organizations that have seen sales growth slow in mature markets. However, there are still questions around the cost, acceptability, quality and pitfalls of conducting clinical trials in emerging regions.
Best Practices®, LLC conducted primary research to inform clinical affairs leaders at medical device companies on emerging approaches to staffing, outsourcing and managing clinical trials outside of the European and U.S. regions.
Critical outsourcing questions addressed in this survey include:
-What are the regions where medical device companies are conducting clinical trials and the percent of patients recruited annually from these regions?
-Which clinical trial activities are best suited for outsourcing?
-What is the appropriate staffing mix (in-house and outsourced) for clinical trials?
-What are the most important competencies for clinical research associates, managers, and directors?
This report will inform Clinical Affairs leaders on these questions and others regarding staffing, outsourcing and managing clinical trials outside of the U.S.
Ethocle Reports has published its latest Market Research Report on Cardiac Valve Repairs - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Ethocle Reports has published its latest Market Research Report on Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Ethocle Reports has published its latest Market Research Report on Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Ethocle Reports has published its latest Market Research Report on Ventricular Assist Devices. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.
Techno-economic analyses of specific Laurolactam production processes, presenting capital investment breakdown, raw materials consumed and operating costs. Know more at www.intratec.us/products/laurolactam-production-processes
Global Markets Direct's, 'Carcinomas - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Carcinomas, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23246/Carcinomas-%E2%80%93-Pipeline-Review,-H1-2013/
Economics of Aminoundecanoic Acid Production ProcessesIntratec Solutions
Impartial feasibility studies focused on Aminoundecanoic Acid manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/aminoundecanoic-acid-production-processes
Top 10 'MUST DO' Hotel Strategies to Boost Direct BookingsTA Fastrack
Listen to Adrian Caruso, Australia's leading hotel business improvement and marketing expert share with you the top 10 'MUST DO' strategies to drive more direct bookings and instantly boost revenue.
Introduction to Machine Learning for newcomers. It will show you some basic concepts like what is supervised learning, unsupervised learning, classification, regression, under/overfitting, clustering, anomaly detection, and how to have some measures. It will illustrates examples through scikit-learn and tensorflow code
The Tools and Levers That Move Sales DevelopmentSales Hacker
The Tools and Levers That Move Sales Development
Daniel Barber, Director of Sales Development and Operations, ToutApp
Sales Hacker Conference, New York City 2015
How to Sell and Market Innovative Products in Nascent MarketsSales Hacker
How to Sell and Market Innovative Products in Nascent Markets
Ash Alhashim, Director of Global Market and Sales Development, Optimizely
Sales Hacker Conference, New York City 2015
The Executive Briefing Service from New Haven Technologies provides MSPs using ConnectWise with executive-level reporting capabilities, dashboards and SmartPhone reports.
The 5 Metrics for Growing Your Team EffectivelySales Hacker
The 5 Metrics for Growing Your Team Effectively by Steve McKenzie, VP of Sales, InsightSquared. This deck was originally presented at Sales Hacker Series Boston on November 18th, 2014.
This is a general pipeline of analysis developed during my 2 years as bio-informatician.
Mainly used on micro-arrays projects but works fine with other data as RNA-seq once you've got your differentially expressed matrix.
A look at the evolution of analytics and its revolutionary potential to transform ordinary businesses, power new business models, enable innovation, and deliver greater value. http://www2.deloitte.com/us/en/pages/deloitte-analytics/articles/analytics-trends.html
Booz Allen Hamilton created the Field Guide to Data Science to help organizations and missions understand how to make use of data as a resource. The Second Edition of the Field Guide, updated with new features and content, delivers our latest insights in a fast-changing field. http://bit.ly/1O78U42
Companyprofilesandconferences.com glad to promote a new report on "Diaxonhit S.A (ALEHT) - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products who provides key information about the company, its major products and brands.
Myriad genetics, inc. product pipeline analysisraja1233
Companyprofilesandconferences.com glad to promote a new report on "Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products who provides key information about the company, its major products and brands.
Cook medical incorporated product pipeline analysisraja1233
Companyprofilesandconferences.com glad to promote a new report on "Cook Medical Incorporated - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products also provides key information about the company, its major products and brands.
Market Research Reports, Inc. has announced the addition of “Vulvar Cancer - Pipeline Insight, 2018” research report to their offering. See more at - http://mrr.cm/UBP
Market Research Reports, Inc. has announced the addition of “Acute Lung Injury - Pipeline Insight, 2018” research report to their offering. See more at - http://mrr.cm/Unn
Companyprofilesandconferences.com glad to promote a new report on "Digna Biotech, S.L. - Product Pipeline Analysis" which are focuses on the development and commercialization of robust clinical therapeutic candidates through partnerships with pharmaceutical companies.
Global Markets Direct's, 'Esophageal Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Esophageal Cancer, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23243/Esophageal-Cancer-%E2%80%93-Pipeline-Review,-H1-2013/
Integra gen s.a (alint) product pipeline analysis, 2014 updateAmbikabasa
Summary IntegraGen S.A (IntegraGen) is a biotechnology service provider. The company provides clinical genomic services to academic researchers and life sciences companies. It offers services such as DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis, and bioinformatics analysis of sequence data. IntegraGen provides sequencing and genotyping of DNA and RNA. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics, and agriculture. It serves patients, clinicians and researchers. IntegraGen partners with illumia, Fluidigm, DNA genotek and Agitent Certified companies.
http://www.researchmoz.us/integragen-sa-alint-product-pipeline-analysis-2014-update-report.html
Co mentis, inc. product pipeline review - 2015Ambikabasa
This report provides comprehensive information on the current therapeutic developmental pipeline of CoMentis, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
http://www.researchmoz.us/comentis-inc-product-pipeline-review-2015-report.html
1. Eqalix, Inc. - Product Pipeline Analysis
Market Research Reports Distributor - Aarkstore.com have vast database on market research reports, company
financials, company profiles, SWOT analysis, company report, company statistics, strategy review, industry
report, industry research to provide excellent and innovative service to our report buyers.
Aarkstore.com have very interactive search feature to browse across more than 2,50,000 business industry
reports. We are built on the premise that reading is valuable, capable of stirring emotions and firing the
imagination. Whether you're looking for new market research report product trends or competitive industry
analysis of a new or existing market, Aarkstore.com has the best resource offerings and the expertise to make
sure you get the right product every time.
2. Eqalix, Inc. - Product Pipeline Analysis
Summary
Eqalix, Inc. (Eqalix) is a medicine development company. It provides novel nano-materials for the repair and
regeneration of diseased, traumatized, and aging tissues. The company has commercial licensing for technologies
to be developed in the fields of aesthetic dermatology, wound treatments, vascular replacements, and traumatic
damage to peripheral nerves. Its pipeline products include plant-protein based nano-fiber scaffolds; and small-
diameter hybrid vessels. The company’s brands include RegeNerve, CardioVessel, MaxiCell3D, RenalEase,
BioSquareEQ and OmegaSkin. Eqalix is headquartered in Reston, Virginia, the US.
It aims to develop technologies in a staged approach and generate revenue from the consumer market to further
commercialization on these technologies. It intends to work closely with co-development partners, and seek
government grants and sponsorships.
This report is a source for data, analysis and actionable intelligence on the Eqalix, Inc. portfolio of pipeline products. The
report provides detailed analysis on each pipeline product with information on the indication, the development
stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date
Each pipeline product is profiled to cover information on product description, function, technology, indication, and
application. The report is also supplemented with a detailed company profile and information on clinical trials,
wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and
in-house analysis by GlobalData’s team of industry experts.
3. Scope
- Detailed company profile with information on business description, key company facts, major products and
services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and
by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and
estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology,
indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status,
trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym,
participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study
type, trial site, trial funding, age eligibility, and gender eligibility.
4. Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices
pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust
return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to
gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline
products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-
value products that your competitor would add in its portfolio? – identify, understand and capitalize.
5. List of Tables 3
List of Figures 3
Key Facts 4
Eqalix, Inc. - Major Products and Services 5
Eqalix, Inc. Pipeline Products by Equipment Type 6
Eqalix, Inc. Pipeline Products by Development Stage 8
Eqalix, Inc. Pipeline Products by Therapy Area 10
BioSquareEQ 12
BioSquareEQ Product Status 12
BioSquareEQ Product Description 12
CardioVessel 13
CardioVessel Product Status 13
CardioVessel Product Description 13
DermaSoy 14
DermaSoy Product Status 14
DermaSoy Product Description 14
MaxiCell3D 15
MaxiCell3D Product Status 15
MaxiCell3D Product Description 15
OmegaSkin 16
OmegaSkin Product Status 16
OmegaSkin Product Description 16
RegeNerve 17
RegeNerve Product Status 17
RegeNerve Product Description 17
RenalEase 18
RenalEase Product Status 18
RenalEase Product Description 18
Eqalix, Inc. - Key Competitors 19
Eqalix, Inc. - Key Employees 20
Eqalix, Inc. - Key Employee Biographies 21
Eqalix, Inc. - Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
6. List of Tables
Eqalix, Inc., Key Facts 1
Eqalix, Inc. Key Pipeline Products by Equipment Type 1
Eqalix, Inc. Key Pipeline Products by Therapy Area 1
Eqalix, Inc. Key Pipeline Products by Development Stage 1
Eqalix, Inc., Key Facts 4
Eqalix, Inc., Major Products and Services 5
Eqalix, Inc. Number of Pipeline Products by Equipment Type 6
Eqalix, Inc. Pipeline Products by Equipment Type 7
Eqalix, Inc. Number of Pipeline Products by Development Stage 8
Eqalix, Inc. Pipeline Products by Development Stage 9
Eqalix, Inc. Number of Pipeline Products by Therapy Area 10
Eqalix, Inc. Pipeline Products by Therapy Area 11
BioSquareEQ - Product Status 12
BioSquareEQ - Product Description 12
CardioVessel - Product Status 13
CardioVessel - Product Description 13
DermaSoy - Product Status 14
DermaSoy - Product Description 14
MaxiCell3D - Product Status 15
MaxiCell3D - Product Description 15
OmegaSkin - Product Status 16
OmegaSkin - Product Description 16
RegeNerve - Product Status 17
RegeNerve - Product Description 17
RenalEase - Product Status 18
RenalEase - Product Description 18
Eqalix, Inc., Key Employees 20
Eqalix, Inc., Key Employee Biographies 21
7. List of Figures
Eqalix, Inc. Key Pipeline Products by Equipment Type 1
Eqalix, Inc. Pipeline Products by Equipment Type 6
Eqalix, Inc. Pipeline Products by Development Stage 8
Eqalix, Inc. Pipeline Products by Therapy Area 10
8. Related Reports
For more information, please visit:
http://www.aarkstore.com/reports/Eqalix-Inc-Product-Pipeline-Analysis-240259.html
Or email us at contact@aarkstore.com or call +919272852585
More Reports
http://www.aarkstore.com/publishers/GlobalData-61.html
• Tornier, Inc. - Medical Equipment - Deals and Alliances Profile
• Hyland Software, Inc. - Medical Equipment - Deals and Alliances Profile
• Ratio, Inc. - Medical Equipment - Deals and Alliances Profile
• YM BioSciences Inc. (YM) - Medical Equipment - Deals and Alliances Profile
• InSightec Ltd. - Medical Equipment - Deals and Alliances Profile
• Exosome Diagnostics, Inc. - Medical Equipment - Deals and Alliances Profile
• ReGen Biologics, Inc. (RGBO) - Medical Equipment - Deals and Alliances Profile
• Oryzon Genomics S.A. - Medical Equipment - Deals and Alliances Profile
• Rutgers, The State University of New Jersey - Medical Equipment - Deals and Alliances Profile
• Rubicon Genomics, Inc. - Medical Equipment - Deals and Alliances Profile
9. Contact Us
Aarkstore E nterprise
T : +912227453309
el
M obile No:+08149852585
Email : contact@aarkstore.com
W ebsite : http:/www.aarkstore.com
/
Blog: http:/www.emarketreports.com
/
http:/teju-aarkstoreenterprise.blogspot.in
/
Follow us on twitter: http:/twitter.com/
/ aarkstoredotcom
http:/in.linkedin.com/ aarkstore
/ in/
http:/www.facebook.com/
/ aarkstoreenterprise
10. Contact Us
Aarkstore E nterprise
T : +912227453309
el
M obile No:+08149852585
Email : contact@aarkstore.com
W ebsite : http:/www.aarkstore.com
/
Blog: http:/www.emarketreports.com
/
http:/teju-aarkstoreenterprise.blogspot.in
/
Follow us on twitter: http:/twitter.com/
/ aarkstoredotcom
http:/in.linkedin.com/ aarkstore
/ in/
http:/www.facebook.com/
/ aarkstoreenterprise